Genotix

Genotix Biotechnologies is a venture-funded startup disrupting the $30B immunodiagnostics industry with a compact, single-molecule detection platform. The company's nanoarray analyzer enables ultrasensitive digital characterization and quantification of proteins and nucleic acids at biological resolution, making early disease detection more accessible outside traditional laboratory settings. Its technology draws on expertise in flow cytometry, mass spectrometry, and immunohistochemistry, targeting clinicians and researchers who need high-sensitivity biomarker testing for pre-symptomatic disease identification.